Exome and whole-genome sequencing for gene discovery: the future is now!

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Identification of OSBPL2 as a novel candidate gene for progressive nonsyndromic hearing loss by whole-exome sequencing.Genetics in medicine : official journal of the American College of Medical Genetics · 2015
   Article
2. Edgotype: a fundamental link between genotype and phenotype.Current opinion in genetics & development · 2013
   Review
3. The genetics of Autism Spectrum Disorders--a guide for clinicians.Current psychiatry reports · 2013
   Review

Corrections and comments

• Comment on
  Analysis of DNA sequence variants detected by high-throughput sequencing.2012
• Comment on
  Detecting false-positive signals in exome sequencing.2012
• Comment on
  An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia.2012

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as